Week In Review: Roche Buys China-Backed GeneWEAVE For $425 Million
August 16, 2015 at 04:41 AM EDT
Roche will pay $190 million up front and up to $235 million in milestones. GeneWEAVE’s Smarticles technology develops innovative molecular diagnostics that identify multidrug-resistant organisms.
